{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:54:55Z","timestamp":1787698495596,"version":"build-2784847793"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study aims to establish and validate a predictive model based on radiomics features, clinical features, and radiation therapy (RT) dosimetric parameters for overall survival (OS) in hepatocellular carcinoma (HCC) patients treated with RT for portal vein tumor thrombosis (PVTT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively reviewed 131 patients. Patients were randomly divided into the training (<jats:italic>n<\/jats:italic> = 105) and validation (<jats:italic>n<\/jats:italic> = 26) cohorts. The clinical target volume was contoured on pre-RT computed tomography images and 48 textural features were extracted. The least absolute shrinkage and selection operator regression was used to determine the radiomics score (rad-score). A nomogram based on rad-score, clinical features, and dosimetric parameters was developed using the results of multivariate regression analysis. The predictive nomogram was evaluated using Harrell\u2019s concordance index (C-index), area under the curve (AUC), and calibration curve.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two radiomics features were extracted to calculate the rad-score for the prediction of OS. The radiomics-based nomogram had better performance than the clinical nomogram for the prediction of OS, with a C-index of 0.73 (95% CI, 0.67\u20130.79) and an AUC of 0.71 (95% CI, 0.62\u20130.79). The predictive accuracy was assessed by a calibration curve.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The radiomics-based predictive model significantly improved OS prediction in HCC patients treated with RT for PVTT.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.906498","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T05:28:30Z","timestamp":1663651710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy"],"prefix":"10.3389","volume":"12","author":[{"given":"Yu-Ming","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsang-En","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chi","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ming","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx030","article-title":"Annual report to the nation on the status of cancer, 1975\u20132014, featuring survival","volume":"109","author":"Jemal","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27311","article-title":"New advances in precision medicine for hepatocellular carcinoma recurrence prediction and treatment","volume":"60","author":"Vilarinho","year":"2014","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000481315","article-title":"Hepatocellular carcinoma with macrovascular invasion: defining the optimal treatment strategy","volume":"6","author":"Costentin","year":"2017","journal-title":"Liver Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijsu.2015.05.009","article-title":"The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus","volume":"20","author":"Zhang","year":"2015","journal-title":"Int J Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.09.003","article-title":"Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma","volume":"43","author":"Addario","year":"2011","journal-title":"Dig Liver Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23485","article-title":"A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma","volume":"51","author":"Cabibbo","year":"2010","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0249426","DOI":"10.1371\/journal.pone.0249426","article-title":"The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: a cohort study","volume":"16","author":"Tiao","year":"2021","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.09.010","article-title":"Molecular therapies for HCC: looking outside the box","volume":"72","author":"Faivre","year":"2020","journal-title":"J Hepatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e18362","DOI":"10.1097\/md.0000000000018362","article-title":"Resection might be a meaningful choice for hepatocellular carcinoma with portal vein thrombosis","volume":"98","author":"Zhang","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0216935","DOI":"10.1371\/journal.pone.0216935","article-title":"Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: the impact of portal vein thrombosis on survival","volume":"14","author":"Woloschak","year":"2019","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ctro.2017.04.003","article-title":"Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus","volume":"4","author":"Holliday","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2017.11.013","article-title":"Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis and systematic review","volume":"129","author":"Rim","year":"2018","journal-title":"Radiother Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i30.6851","article-title":"Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"22","author":"Yu","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5847","article-title":"Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion","volume":"4","author":"Yoon","year":"2018","journal-title":"JAMA Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.03.041","article-title":"Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines","volume":"89","author":"Hong","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyl006","article-title":"Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy","volume":"36","author":"Lin","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9690","article-title":"Comparison of values of CT and MRI imaging in the diagnosis of hepatocellular carcinoma and analysis of prognostic factors","volume":"17","author":"Wang","year":"2019","journal-title":"Oncol Lett"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.09.017","article-title":"CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis","volume":"9","author":"Yu","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051138","article-title":"[18F]FDG-PET\/CT radiomics for prediction of bone marrow involvement in mantle cell lymphoma: a retrospective study in 97 patients","volume":"12","author":"Mayerhoefer","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00494","article-title":"Discrimination of pancreatic serous cystadenomas from mucinous cystadenomas with CT textural features: based on machine learning","volume":"9","author":"Yang","year":"2019","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12880-019-0321-9","article-title":"Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Med Imaging"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.521831","article-title":"Application of radiomics analysis based on CT combined with machine learning in diagnostic of pancreatic neuroendocrine tumors patient\u2019s pathological grades","volume":"10","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.604288","article-title":"Survival prediction in gallbladder cancer using CT based machine learning","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-18-3065","article-title":"Prognostic value of deep learning PET\/CT-based radiomics: potential role for future individual induction chemotherapy in advanced nasopharyngeal carcinoma","volume":"25","author":"Peng","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-020-01552-2","article-title":"Contrast-enhanced CT-based textural parameters as potential prognostic factors of survival for colorectal cancer patients receiving targeted therapy","volume":"23","author":"Zhao","year":"2020","journal-title":"Mol Imaging Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040814","article-title":"External validation of an MRI-derived radiomics model to predict biochemical recurrence after surgery for high-risk prostate cancer","volume":"12","author":"Bourbonne","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061432","article-title":"Association of a CT-based clinical and radiomics score of non-small cell lung cancer (NSCLC) with lymph node status and overall survival","volume":"12","author":"Botta","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-020-01626-8","article-title":"Applications of radiomics and machine learning for radiotherapy of malignant brain tumors","volume":"196","author":"Kocher","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.228106","article-title":"Pretreatment 18F-FDG PET\/CT radiomics predict local recurrence in patients treated with stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentric study","volume":"61","author":"Dissaux","year":"2020","journal-title":"J Nucl Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/0036850421997295","article-title":"A radiomics model of predicting tumor volume change of patients with stage III non-small cell lung cancer after radiotherapy","volume":"104","author":"Yan","year":"2021","journal-title":"Sci Prog"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30413-3","article-title":"A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study","volume":"19","author":"Sun","year":"2018","journal-title":"Lancet Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.11220","article-title":"Radiomics predicts survival of patients with advanced non\u2212small cell lung cancer undergoing PD\u22121 blockade using nivolumab","volume":"19","author":"Nardone","year":"2020","journal-title":"Oncol Lett"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-017-0850-7","article-title":"Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT","volume":"123","author":"Nardone","year":"2018","journal-title":"Radiol Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030761","article-title":"Extended texture analysis of non-enhanced whole-body MRI image data for response assessment in multiple myeloma patients undergoing systemic therapy","volume":"12","author":"Ekert","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.567160","article-title":"Value of 18F-FDG PET\/CT-based radiomics nomogram to predict survival outcomes and guide personalized targeted therapy in lung adenocarcinoma with EGFR mutations","volume":"10","author":"Yang","year":"2020","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmir.2019.07.010","article-title":"Personalized breast cancer treatments using artificial intelligence in radiomics and pathomics","volume":"50","author":"Tran","year":"2019","journal-title":"J Med Imaging Radiat Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.574228","article-title":"Radiomic feature-based predictive model for microvascular invasion in patients with hepatocellular carcinoma","volume":"10","author":"He","year":"2020","journal-title":"Front Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1186\/s12885-018-5024-z","article-title":"Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients","volume":"18","author":"Zheng","year":"2018","journal-title":"BMC Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.21037\/atm-20-6116","article-title":"Predicting the survival rate of patients with hepatocellular carcinoma after thermal ablation by nomograms","volume":"8","author":"Zhou","year":"2020","journal-title":"Ann Transl Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26977","article-title":"MRI-Based radiomics: associations with the recurrence-free survival of patients with hepatocellular carcinoma treated with conventional transcatheter arterial chemoembolization","volume":"52","author":"Song","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0706-0","article-title":"MRI-Based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma","volume":"122","author":"Wang","year":"2020","journal-title":"Br J Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01196","article-title":"Radiomics analysis on multiphase contrast-enhanced CT: a survival prediction tool in patients with hepatocellular carcinoma undergoing transarterial chemoembolization","volume":"10","author":"Meng","year":"2020","journal-title":"Front Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1186\/s12885-017-3847-7","article-title":"Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy","volume":"17","author":"Cozzi","year":"2017","journal-title":"BMC Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-0125","article-title":"LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity","volume":"78","author":"Nioche","year":"2018","journal-title":"Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.21037\/tro.2019.07.03","article-title":"Integrated radiomic model for predicting the prognosis of esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoradiation","volume":"3","author":"Hou","year":"2019","journal-title":"Ther Radiol Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.569435","article-title":"Utility of radiomics for predicting patient survival in hepatocellular carcinoma with portal vein tumor thrombosis treated with stereotactic body radiotherapy","volume":"10","author":"Wu","year":"2020","journal-title":"Front Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12041051","article-title":"Radiomics-based outcome prediction for pancreatic cancer following stereotactic body radiotherapy","volume":"12","author":"Parr","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(20)30034-6","article-title":"MRI-Guided adaptive radiotherapy for liver tumours: visualising the future","volume":"21","author":"Witt","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.906498\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T05:28:36Z","timestamp":1663651716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.906498\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":51,"alternative-id":["10.3389\/fonc.2022.906498"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.906498","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"article-number":"906498"}}